3 Pages

Tax - Ch6 Solutions

Course: TAX 101, Fall 2007
School: Wisc La Crosse
Rating:
 
 
 
 
 

Word Count: 1093

Document Preview

6 THE CHAPTER ACQUISITION, USE, AND DISPOSAL OF DEPRECIABLE PROPERTY KC 6-1 [ITA: 13(21), 20(1)(a); Reg. 1100(1),(2) - Additions to the pool exceed Disposals] Class 8 UCC balance, beginning of year Purchases Disposals $10,000 $40,000 (3,500) CCA: $10,000 x 20% $36,500 x 20% x UCC balance, end of year $(2,000) (3,650) 36,500 46,500 (5,650) $40,850 K C 6 -3 [ITA: 13(1) Recapture] Class 12 UCC balance,...

Register Now

Unformatted Document Excerpt

Coursehero >> Wisconsin >> Wisc La Crosse >> TAX 101

Course Hero has millions of student submitted documents similar to the one
below including study guides, practice problems, reference materials, practice exams, textbook help and tutor support.

Course Hero has millions of student submitted documents similar to the one below including study guides, practice problems, reference materials, practice exams, textbook help and tutor support.
6 THE CHAPTER ACQUISITION, USE, AND DISPOSAL OF DEPRECIABLE PROPERTY KC 6-1 [ITA: 13(21), 20(1)(a); Reg. 1100(1),(2) - Additions to the pool exceed Disposals] Class 8 UCC balance, beginning of year Purchases Disposals $10,000 $40,000 (3,500) CCA: $10,000 x 20% $36,500 x 20% x UCC balance, end of year $(2,000) (3,650) 36,500 46,500 (5,650) $40,850 K C 6 -3 [ITA: 13(1) Recapture] Class 12 UCC balance, beginning of year Purchases Disposals Recapture of CCA UCC balance, end of year $1,300 $ 0 (2,000) (2,000) (700) 700 $ 0 K C 6 -5 [Reg. 1100(1)(a.2), (c); 1100(2) 1/2 year rule; Reg. 1100(3) - Short taxation year; Reg 1101(5b.1) separate class election] Class 1: (20X6) Capital cost of building CCA: $100,000 x 6% x x 245/365 days UCC $100,000 (2,014) 97,986 (20X7) CCA: $97,986 x 6% UCC (5,879) $ 92,107 Class 14: (20X6) CCA: $60,000 x (20X7) CCA: $60,000 x 245 (# of days owned in 20X6) = $4,025 3,652 (# of days in life of the franchise) 365 (# of days owned in 20X7) 3,652 (# of days in life of the franchise) = $6,000 [Note the number of days in the life of the franchise includes 2 additional days for the two leap years that would occur in the 10 years]. The building is an addition to Class 1. Since the non-residential building was constructed after March 18, 2007, it has a 6% CCA rate based on the declining-balance [Reg. 1000(1)(a.2)] provided Kayla elects to place the building in a separate Class 1 [Reg 1101(5b.1)]. The solution assumes she did so. The election is made by attaching a letter to the tax return for the year In which the building is acquired. The franchise, having a limited legal life (10 years) is an addition to Class 14, a straightline class. CCA on Class 14 is calculated by multiplying the cost by the number of days the franchise is owned in the year divided by the total number of days in its legal life [Reg. 1100(1)(c)]. For Class 1, the amount of CCA that can be claimed in the year the asset is acquired is restricted to one-half the normal rate [Reg. 1100(2)]. This rule does not apply to Class 14. Kayla, being an individual, has a calendar year-end for her business [ITA 249]. Therefore, the first taxation year is a short taxation year consisting of 245 days (May 1 to December 31). CCA for Class 1 must be prorated by the number of days in the taxation year divided by 365 [Reg. 1100(3)]. Prorating for a short taxation year does not apply to Class 14. K C 6 -6 [ITA: 20(1)(a); Reg. 1100(1)(b) Class 13 CCA] Class 13: 20X1: UCC balance, beginning of year Purchases Disposals $ $84,000 ( 0) CCA ($12,000 x ) UCC balance, end of year 20X2: UCC balance, beginning of year Purchases Disposals 0 84,000 84,000 (6,000) $78,000 $ 78,000 $30,000 ( 0) 30,000 108,000 CCA ($12,000 + $2,500) UCC balance, end of year 20X3: UCC balance, beginning of year Purchases Disposals (14,500) $ 93,500 $93,500 $ ( 0 0) CCA ($12,000 + $5,000) UCC balance, end of year 0 93,500 (17,000) $76,500 Leasehold improvements: 20X1 improvement: $84,000 (capital cost) 4 (lease term) + 3 (1st option term) = $12,000 Limited to 1/5 x $84,000 = $16,800 20X2 improvement: $30,000 (capital cost) = $ 5,000 3 (remaining lease term) + 3 (1st option term) Limited to 1/5 x $30,000 = $6,000 The Class 13 half-year rule in Reg. 1100(1)(b) applies. Therefore, in 20X1, the CCA is reduced from $12,000 to $6,000, and in 20X2, the CCA of $5,000 is reduced to $2,500. K C 6 -9 [ITA: 14(1), (5); 20(1)(b) - CEC] Cumulative eligible capital account: Year 1: Opening balance Purchase of goodwill ($100,000 x ) Deduction ($75,000 x 7 %) Year 2: Deduction ($69,750 x 7%) Year 3: Sale of goodwill ($140,000 x ) Negative balance $ 0 75,000 75,000 (5,250) 69,750 (4,883) 64,867 (105,000) $ (40,133) Business income: Recapture of CEC previously deducted ($5,250 + $4,883) Taxable portion of excess ($40,133 - $10,133) x 2/3 or ($140,000 - $100,000) x 1/2 Business income $10,133 20,000 $30,133 Solution to P 6-2 1. The equipment qualifies as a Class 8 asset with a capital cost allowance rate of 20%. The undepreciated capital cost of the Class at the end of 20X1 (the year before the sale) is as follows: [Reg. 1100(1)(a)(viii)] 20X0 Purchase CCA 20% x $10,000 x 1/2 20X1 CCA 20% x $9,000 Undepreciated capital cost $10,000 (1,000) 9,000 (1,800) $ 7,200 In 20X2 the following occurs: a) Sale $3,000: UCC Proceeds Terminal for loss (deduction) [ITA 20(16)] b) Sale for $8,000: UCC Proceeds Recapture [ITA 13(1)] c) Sale for $12,000: UCC Proceeds (limited to original cost) Recapture [ITA 13(1)] $ 7,200 (3,000) 4,200 (4,200) $ 0 $ 7,200 (8,000) (800) 800 $ 0 $ 7,200 (10,000) (2,800) 2,800 $ 0 Plus: Proceeds of sale Original cost Capital gain $12,000 10,000 $ 2,000 Taxable (1/2) $ 1,000 2. If $1,000 of new equipment was purchased on the last day of the fiscal year in a) and b) above the answer would be changed as follows: a) UCC Purchase Sale $ 7,200 1,000 (3,000) 5,200 (1,040) $ 4,160 CCA 20% of $5,200 The purchase eliminates the terminal loss of $4,200 because there is an asset left in the pool. It would be advantageous to delay the purchase for one day to the first day of the next taxation year as this would permit the full terminal loss of $4,200 in 20X2 leaving the $1,000 purchase in 20X3 for normal CCA. Cash flow from tax savings would be enhanced. b) UCC Purchase Sale $ 7,200 1,000 (8,000) 200 (40) $ 160 CCA 20% of $200 The purchase of $1,000 completely eliminates $800 of recapture and therefore enhances the current year's cash flow. Effectively, because of the impending recapture, $840 of the $1,000 purchase price is deducted in 20X2 ($800 + $40). If the $1,000 was delayed to the beginning of next year the full $800 recapture would occur in 20X2 Therefore the delay is not advantageous. Solution to P 6-3 1. Depreciable property: Class UCC beginning of year Purchases Sale (up to original cost) Recapture CCA: $190,000(20%) + $14,000(20%)(1/2) $30,000(50%)(1/2) (note 1) 1. 8. $200,000 $190,000 14,000 . 204,000 (230,000) (30,000) 30,000 $ Cumulative Eligible capital: Beginning balance Addition (3/4) of $10,000 20X1 deduction 7% of $7,500 . 0 (39,400) . $164,600 $ 0 7,5000 (525) 29 . $ 0 30,000 . 30,000 (7,500) $ 25,500 $6,975 Capital Gain (Building) Proceeds Cost Capital gain Taxable (1/2) of $30,000 $260,000 230,000 $ 30,000 $ 15,000 Effect on 20X1 income: Business income Recapture Less: CCA (39,400 + 7,500) CEC write-off Decrease Taxable Capital Gain Net decrease $ 30,000 (46,900) (525) (17,425) 15,000 $ (2,425) Note 1 Manufacturing and processing equipment assumed purchased between March 19, 2007 and December 31, 2013. Otherwise, Class 43. 2. Yes. The company could acquire a replacement building in 20X2 provided it is used for similar purposes in conducting a business activity. The replacement in 20X2 would permit the 20X1 recapture to be reduced to zero and reduce the cost of the replacement building [ITA 13(4)]. A similar deferral is available for the capital gain on the building [ITA 44(1)]. If the cost of the new building equals or exceeds the proceeds for the sold building ($260,000) the entire gain can be deferred. This is discussed in Chapter Eight. The above replacement property rules apply where the replacement property is acquired within one year of 12 months after the end of the taxation year of the sale and applies only to real estate used in a business and eligible capital property [ITA 44(1),(5), 13(4),(4.1), 14(6),(7)]. Solution to P 6-8 Business income: Income per financial statements [ITA 9(1)] Imputed salary Amortization [ITA 18(1)(b)] CCA on leasehold improvements (Class 13) Original 1/10 ($12,000) New 1/9 ($18,000) = $2,000 (1/2) CCA on paving parking area (Class 17) $12,000 x 8% x Legal fees for land purchase (capital item) [ITA 18(1)(b)] Legal fees for obtaining mortgage (1/5 is deductible as a cost of obtaining financing) add back - 4/5 x $1,200 [ITA 20(1)(e)] Auto operating costs Personal portion is 75% (to and from work 20% + personal 55%) $4,300 x 75% [ITA 18(1)(h)] CCA on auto (Class 10.1) Capital Cost is limited to $30,000 + tax CCA - $30,000 x 30% x 1/2 = $4,500 * [ITA 13(7)(g)] Business portion - $4,500 x 25% Reserve for potential sales returns [ITA 18(1)(e)] $ 9,500 38,000 3,500 $1,200 1,000 (2,200) ( 480) 1,000 960 3,225 (1,125 ) 10,000 $62,380 * Assuming that the retail business is a HST registrant, the HST has not been added to the cost of the automobile. Total income: ITA 3(a) Business income Other income - pension ($4,000 x 12) ITA 3(d) Allowable business investment loss Sale of shares 1/2 ($12,000 - $20,000) $ 62,380 48,000 110,380 (4,000) $106,380
Find millions of documents on Course Hero - Study Guides, Lecture Notes, Reference Materials, Practice Exams and more. Course Hero has millions of course specific materials providing students with the best way to expand their education.

Below is a small sample set of documents:

Wisc La Crosse - TAX - 101
CHAPTER 7INCOME FROM PROPERTYK C 7 -1[ITA: 12(1)(c), 12(3), (4), (11) - Interest income]In both cases $1,236 of interest will be earned and received on the maturity of the bondon October 31, Year 3.Nov 1, Year 1 to Oct 31, Year 2 Nov 1, Year 2 to Oc
Wisc La Crosse - TAX - 101
CHAPTER 7INCOME FROM PROPERTYSolution to P 7-2Property income:InterestShare of interest earned by partnership(25% of $8,000) [ITA 12(1)(l)]Interest from daughter [ITA 12(1)(c), 74.1(2)]Investment certificate (note 1)Dividends [ITA 12(1)(j), (k),
Wisc La Crosse - TAX - 101
CHAPTER 8GAINS AND LOSSES ON THE DISPOSITION OF CAPITALPROPERTYCAPITAL GAINSSolutions to Key Concept QuestionsK C 8 -1[ITA: 40(1)(iii) Capital gains reserve]The minimum taxable capital gain to be reported is $50,000 in 20X1, $30,000 in 20X2and $40,
Wisc La Crosse - TAX - 101
CHAPTER 8GAINS AND LOSSES ON THE DISPOSITION OF CAPITALPROPERTYCAPITAL GAINSSolution to P 8-6This problem emphasizes that the determination of capital gains and losses must be analyzed inconjunction with the restrictions of the aggregating formula fo
Wisc La Crosse - TAX - 101
Buckwold and Kitunen, Canadian Income Taxation, 2008-2009 Ed.CHAPTER 8GAINS AND LOSSES ON THE DISPOSITION OF CAPITALPROPERTYCAPITAL GAINSReview Questions1.A capital gain or capital loss is the gain or loss realized from the disposition ofcapital pr
Wisc La Crosse - TAX - 101
CHAPTER 9: OTHER INCOME, OTHER DEDUCTIONS, ANDSPECIAL RULES FOR COMPLETING NET INCOME FOR TAXPURPOSESSolutions to Key Concept QuestionsK C 9 -6[ITA: 62; IT-178R3 Moving expenses]Moving expenses in respect of an eligible relocation are deductible. Th
Wisc La Crosse - TAX - 101
Buckwold and Kitunen, Canadian Income Taxation, 2011-2012 Ed.CHAPTER 9OTHER INCOME, OTHER DEDUCTIONS, AND SPECIAL RULESFOR COMPLETING NET INCOME FOR TAX PURPOSESSolution to P 9-11. Property left to children:Capital property left to children is deeme
Wisc La Crosse - TAX - 101
CHAPTER 10INDIVIDUALS: DETERMINATION OF TAXABLE INCOMEAND TAXES PAYABLEKC 10-7[ITA: 56(1)(a.2), 60(c), 60.03, 117(2), 117.1(1), 118(1)(a), 118(2),(3), 118.8 Federaltax and Senior credits](i) Pension income not split:Federal income tax:15% x $41,54
Wisc La Crosse - TAX - 101
CHAPTER 10INDIVIDUALS: DETERMINATION OF TAXABLE INCOMEAND TAXES PAYABLESolution to P 10-23(a) Income from law practice (business)$97,0003(b) Taxable capital gains:Public corporation shares 1/2($80,000)Small business corporation shares(assumed to
Wisc La Crosse - TAX - 101
CHAPTER 11CORPORATIONSAN INTRODUCTIONKC 11-3[ITA: 110.1(1), 111(1)(a),(b), 112(1), 127(3) Taxable income, Political tax credit]Nelson Ltds taxable income is $215,000.Net incomeDividends from taxable Canadian corporationsDonations (limited to 75% x
Wisc La Crosse - TAX - 101
Buckwold and Kitunen, Canadian Income Taxation, 2010-2012 Ed.CHAPTER 11CORPORATIONSAN INTRODUCTIONSolution to P 11-1Part 1(a)Net income for tax purposes:Profits from operationsHead officeAlberta branchDividend incomeTaxable capital gainsNet in
CSU Long Beach - MGMNT - 425
Instructions for Analysis of Case 61. How strong are the competitive forces in the movie rental marketplace? Do a five forces analysis to supportyour answer.Below is an analysis of five forces model of competition in the movie rental industry:Rivalry
Universitas Gadjah Mada - JTETI - 00
Keaslian Penelitian dan KedalamanPenelitiTahunJudulMetode yangdipakaiHasilKhan, dkk.2011ContentBasedImageRetrievalApproachesforDetectionofMalarial Parasite inBlood ImagesSistem yang dibangunmemiliki sensitivitassebesar 85.5% denganni
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
Chng 8Cc ng dng trong y dcI. M uCho n nay, c l thnh tu cng ngh sinh hc c th hin r ntnht l lnh vc y hc nh liu php protein v liu php gen cha trmt s bnh him ngho (ung th, nhim virus v hin ang th nghimcha tr bnh AIDS.) cng nh chn on bnh (vim gan, st xut
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
Phn ICc khi nim v nguyn l c bnNhp mn Cng ngh sinh hc5Chng 1M uI. nh ngha cng ngh sinh hc1. nh ngha tng qutC nhiu nh ngha v cch din t khc nhau v cng ngh sinhhc ty theo tng tc gi, nhng tt c u thn g nht v khi nim c bnsau y:Cng ngh sinh hc l qu trn
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
Chng 9Cc ng dng trong mi trngI. M uNh chng ta bit, mi trng sng hin ang b nhim trm trng,gii quyt nn cht thi vn l vn ht sc nan gii, c bit l cht thicng nghip nh hng rt ln n mi sinh. Ngoi ra, mt khi lng lncht thi dn dng, rc thnh ph, ph phm nng nghip. cn
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
MC LCTrangLI NI UPhn I. CC KHI NIM V NGUYN L C BNChng 1. M UI. nh ngha cng ngh sinh hc1. nh ngha tng qut1.1. Cng ngh sinh hc truyn thng1.2. Cng ngh sinh hc hin i5666772. Ni dung khoa hc ca cng ngh sinh hc3. Cc lnh vc ng dng ca cng ngh sinh
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
Li ni uCng ngh sinh hc l ngnh khoa hc ng dng hiu bit ca conngi v cc h thng sng s dng cc h thng ny hoc cc thnhphn ca chng cho cc mc ch cng nghip. y l mt ngnh mi nhn,hin ang c c th gii quan tm do c tc pht trin nhanh chng vang to ra mt cuc cch mng sinh
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
NH XUT BN I HC HUa ch: 01 in Bin Ph, Hu - in thoi: 054.834486Chu trch nhim xut bn:Gim c: Nguyn Xun KhotTng bin tp: Hong Hu HaNgi phn bin:PGS. TS. L Trn BnhBin tp ni dung:PGS. Nguyn KhiBin tp k thut-m thut:Hong MinhTrnh by ba:Nguyn Hong LcCh b
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
PGS. TS. Nguyn Hong LcGio trnhNhp mn Cng ngh sinh hcNh xut bn i hc HuNm 2007
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
LI M UTi sao phi c bit quan tm n lysine nc ta?C 4 acid amin thit yu hay b thiu ht trong khu phn n nc ta: llysine, threonine, tryptophan v methionine. Trong , lysine c quan tmhn c v c nhu cu kh cao nhng li thng b thiu ht nht trong cckhu phn n ch yu da
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
AI HOC DC HA NOITiu Lun Cng ngh sinh hcCh Ti t hp ADN v ng dng trong sn xut thucNhm sinh vin thc hin: Phm Th Thy An T 2Phm Th Thu H T 2Lp M1K62i hc Dc H NiH Ni -2010I.t vn :Cng ngh ADN ti t hp c th coi l trung tm ca lnh vc cng ngh sinh h c.Cng
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
Cng ngh ln menDownload Agriviet.comBi 1 :SN XUT SINH KHI VI KHUN ACETOBACTER XYLINUMCH BIN NATA DE COCONata de coco l mt sn phm ln men truyn thng ca Philippines, c snxut t nc da ln men bi mt loi vi khun len men dm, c tn l Acetobacterxylinum. Nata d
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
AI HOC DC HA NOITiu Lun Cng ngh sinh hcCh Ti t hp ADN v ng dng trong sn xut thucNhm sinh vin thc hin: Phm Th Thy An T 2Phm Th Thu H T 2Lp M1K62i hc Dc H NiH Ni -2010I.t vn :Cng ngh ADN ti t hp c th coi l trung tm ca lnh vc cng ngh sinh h c.Cng
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
ScribdUpload a DocumentSearch Books, Presentations, Business, Academics.ExploreDocumentsBooks - FictionBooks - Non-fictionHealth & MedicineBrochures/CatalogsGovernment DocsHow-To Guides/ManualsMagazines/NewspapersRecipes/MenusSchool Work+ al
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
Mu trng lg ng 2 bi: V Na2S2O3 = 26.5mlBi ethanol:MuV Na2S2O3 lg ngVS mg ng tra bngC% ngV Na2S2O3 lg cn cnKhi im15.710.835.02KT120.75.818.54KT223.13.410.68KT323.92.68.1629.136.0529.2Bi calci lactatMuK1KT1V Na2S2O320.2521.4
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
Ch 11ngVn g ia nhtro ng qu trnh xy dngc h ng ha x h iN i dung1. V tr, chc nng ca gia inh trong2. Nh ng iu kin v tin xydnggia nh trong qu tr x dngnh ychngha x hi3. Nh ng nh hng cbn v mt svn ra vi vic x dng gia tiy nh Vit Nam hin nay
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
Ch ng VIIIC CU XH GC VLIN MINH GIA GCCN V I NNG DN V TR TH CTRONG QU TRNH XY D NG CH NGHA X H INi dung1. C cu XH-GC trong qu trnh xy d ng CNHX2. Lin minh cng nng tr trong qu trnh xy d ng CNXH3. C cu XH GC v lin minh cng nng tr th c trong qu trnh xy
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
Chng IIIS MNH LCH S CA GCCNNi dung1. Khi nim GCCN2. Ni dung s mnh lch s ca GCCN3. Nhng iu kin khch quan quy nh s mnh lch s ca GCCN4. Tnh tt yu, quy lut hnh thnh v pht tri n ng ca GCCN5. Mi quan h gia CS vi GCCNI.KHI NIM GCCNC.Mc v Angghen s dng
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
Chng IV TR, I TNG, PHNG PHP NGHIN CU CNXHKHNi dung1.2.3.4.5.Khi nim CNXHKHi tng nghin cu ca CNXHKHPhm vi kho st v vn dng ca NCXHKHCc phng php c th ca CNXHKHChc nng v nhim v ca CNXHKHPhn bit CNXH v XHCN Ging nhau v bn cht- L l tng, hc thuyt
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
Cc thng sdc ng hc c bnThS. Phan Qunh LanB mn Dc lm sng Trng H Dc HNMc tiu:1. Nu c nh ngha ca:SKD, Vd, Cl v t1/22. Trnh by c cch tnh ca: SKD, Vd, Cl v t1/23. Nu ngha ca cc thng s ny trong iu tr.Ti liu tham kho1. B mn Dc lm sng, trng H Dc H ni(20
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
S bin i cc thng sdc ng hc c bn bnh nhn suy gim chcnng gan thnThS. Phan Qunh LanB mn Dc lm sng Trng H Dc HNMc tiu:1. Trnh by s bin i ca SKD, Vd, Cl v t1/2 bnh nhn suy gan.2. Trnh by s bin i ca SKD, Vd, Cl v t1/2 bnh nhn suy thn.3. Nu c 3 quan im
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
nguyn tc s dngthuc gim auThS. Phan Qunh LanB mn Dc lm sng Trng H Dc H ni1Mc tiu:1. Phn tch bn nguyn tc s dng thucgim au trung ng2. Phn tch bn nguyn tc s dng thucgim au ngoi vi2Ti liu tham kho1. B mn DLS - trng H Dc HN (2006), Dc lmsng, NXB Y
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
MC TIU HC TP DC LM SNGBi : Ni dung v cch tip cn ca Dc s lm sng.- Cc tiu chun la chn thuc hp l- Lit k + phn tch ni dung, k nng ca hng dn iu tr- Cc ch tiu quy nh nhm m bo s dng thuc hp lChng I: Cc thng s dc ng hc c bn:- nh ngha v cch tnh: SKD, Vd, Cl,
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
S DNG THUC CHOCC I TNG C BITGing vin:Ths Phan Qunh LanBm Dc lm sng- trng H Dc H ni1PH NPH NCHO CON BCHO CON BPH NPH NC THAIC THAII TNGI TNGC BITC BITTR EMTR EMNG CAO TUNGII CAO TUII2Mc tiu:1. Phn tch c nh hng ca thuc dng choPNCT i
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
BENZATHIN BENZYLPENICILINBenzathinum benzylpenicillinum(C16H18N2O4S)2C16H20N2P.t.l: 909,0Benzathin benzylpenicilin l phc hp ca (1:2) N,N-dibenzylethan-1,2-diamin vi acid (2S,5R,6R)-3,3dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]he
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
KETOPROFENv ng phn i quangC16H14O3P.t.l: 254,3Ketoprofen l acid (2RS)-2-(3-benzoylphenyl)propanoic, phi cha t 99,0 n 100,5% C 16H14O3,tnh theo ch phm lm kh.Tnh cht:Bt kt tinh trng hay gn nh trng, thc t khng tan trong n c, r t tan trong aceton, etha
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
HYDROXYETHYLCELLULOSEHydroxyethylcellulosumHydroxyethylcellulose l cellulose c O-(2-hydroxyethyl) ha mt phn.Tnh chtHt hay bt trng, trng ng hay trng xm. Tan trong nc nng v n c l nh t o dung d chkeo, thc t khng tan trong aceton, ethanol 96% v toluen.n
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
ACETAZOLAMIDAcetazolamidumC4H6N4O3S2P.t.l: 222,2Acetazolamid l N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamid, phi ch a t 98,5 n 101,0%C4H6N4O3S2, tnh theo ch phm lm kh.Tnh chtBt kt tinh trng hay gn nh trng.Rt kh tan trong nc, kh tan trong ethanol
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
DIETHYL PHTALATDiethylis phthalasC12H14O4P.t.l: 222,2Diethyl phtalat la diethyl benzen-1,2-dicarboxylat, phai cha t 99,0en 101,0% kl/kl C12H14O4.Tnh ch a tChat long sanh, trong suot, khong mau hoac co mau vang ratnhat. Thc te khong tan trong nc, h
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
TETRACYCLIN HYDROCLORIDTetracyclini hydrochloridum HClHHClC22H24N2O8HClP.t.l: 480,9Tetracyclin hydroclorid l (4S,4aS,5aS,6S,12aS)-4-(Dimethylamino)-3,6,10,12,12a-pentahydroxy6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracen-2-carboxamid hyd
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
PHENOXYMETHYLPENICILIN KALIPhenoxymethylpenicillinum kalicumC16H17KN2O5SP.t.l: 388,5Phenoxymethylpenicilin kali l mui kali ca acid (2 S,5R,6R)-3,3-dimethyl-7-oxo-6[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptan-2-carboxylic, c s n xu t b ngcc
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
ERYTHROMYCIN STEARATErythromycini stearasR1ErythromycinABCCng thcC55H103NO15C55H103NO14C54H101NO15R1OHHOHR2CH3CH3HP.t.l: 1018,0Erythromycin stearat l hn hp cc mui stearat c a erythromycin v acid stearic.Thnh ph nchnh l (3R,4S,5S,6R,7R
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
CEFAZOLIN NATRICefazolinum natricumC14H13N8NaO4S3P.t.l: 476,5Cefazolin natri l mui natri ca acid (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulphanyl]-methyl]-8oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carboxylic ph i
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
CLORAMPHENICOL SUCINAT NATRIChloramphenicoli natrii succinasng phn 1: R1 = CO-CH2-CH2-CO2Na, R3 = Hng phn 3: R1 = H, R3 = CO-CH2-CH2-CO2NaC15H15Cl2N2NaO8P.t.l: 445,2Cloramphenicol natri sucinat l hn hp vi t l khc nhau c a natri (2 R,3R)-2[(dicloroac
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
TIMOLOL MALEATTimololi maleasC13H24N4O3S.C4H4O4P.t.l: 432,5Timolol maleat la (2S)-1-[(1,1-dimethylethyl)amino]-3-[4-(morpholin-4-yl)-1,2,5thiadiazol-3-yl]oxy]propan-2-ol (Z)-butenedioat, phai cha t 98,5 en 101,0%C13H24N4O3S.C4H4O4, tnh tren che pham
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
PHENOXYMETHYLPENICILINPhenoxymethylpenicillinumC16H18N2O5SP.t.l: 350,4Phenoxymethylpenicilin l acid (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia1-azabicyclo[3.2.0]heptan-2-carboxylic, c sn xut b ng cch nui c y ch ng Penicilliumnotatu
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
CLOXACILIN NATRICloxacillinum natricumH2OC19H17ClN3NaO5S H2OP.t.l: 475,9Cloxacilinnatrilnatri(2S,5R,6R)-6-[3-(2-clorophenyl)-5-methylisoxazol-4yl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan-2-carboxylat,ph icha t 95,0 n
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
ACETYLCYSTEINAcetylcysteinumC5H9NO3SP.t.l: 163,2Acetylcystein l acid (2R)-2-(acetylamino)-3-sulfanylpropanoic, phi ch a t 98,0 n 101,0%C5H9NO3S, tnh theo ch phm lm kh.Tnh chtBt kt tinh trng hoc tinh th khng mu.D tan trong nc v trong ethanol 96%, t
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
ACID NALIDIXICAcidum nalidixicumC12H12N2O3P.t.l: 232,2Acid nalidixic l acid 1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridin-3-carboxylic, ph i ch a t 99,0 n 101,0% C12H12N2O3, tnh theo ch phm lm kh.Tnh chtBt kt tinh mu trng ng hay vng nht.Thc
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
CALCI GLUCONATCalcii gluconasH2OC12H22CaO14. H2OP.t.l: 448,4Calci gluconat la calci D-gluconat monohydrat, phai cha t 98,5en 102,0% C12H22CaO14. H2O.Tnh chat, nh tnh, tap chat hu c va acid boric, sacarose va cac ngkh, nh lngTien hanh theo chuyen
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
LINCOMYCIN HYDROCLORIDLincomycini hydrochloridum HCl H2OC18H34N2O6S .HCl .H2OP.t.l: 461,0Lincomycin hydroclorid ch yu l methyl 6,8-dideoxy-6-[(2 S,4R)-1-methyl-4-propylpyrolidin-2yl]carbonyl]amino]-1-thio-D-erythro-D-galacto-octopyranosid hydroclorid
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
ROXITHROMYCINRoxithromycinumC41H76N2O15P.t.l: 837,0Roxithromycin l (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-4-[(2,6-dideoxy-3- C-methyl-3-Omethyl-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-10-[(E)-[(2methoxyethoxy)methoxy]imino]-3,5,7,9,11,13-he
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
CC MACROGOLMacrogolaHn hp cc polymer c cng thc chung H-(OCH 2-CH2)n-OH trong n l s lng trungbnh cc nhm oxyethylen. Cc macrogol c phn lo i theo s ch kh i l ng phn t trungbnh. Trong ch phm c th c cha cht bo qun.Tnh chtLoi30040060010001500300033
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
CALCI GLUCONATCalcii gluconasH2OC12H22CaO14. H2OP.t.l: 448,4Calci gluconat la calci D-gluconat monohydrat, phai cha t 98,5 en102,0% C12H22CaO14. H2O.Tnh chat, nh tnh, tap chat hu c va acid boric, sacarose va ng kh, nhlngTien hanh theo chuyen luan
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
ALOPURINOLAllopurinolumC5H4N4OP.t.l: 136,1Alopurinol l 1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-on, phi cha t 98,0 n 102,0% C 5H4N4O,tnh theo ch phm lm kh.Tnh chtBt trng hay gn nh trng.Rt kh tan trong nc v trong ethanol 96%, tan trong cc dung dch
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
QUININ DIHYDROCLORIDChinini dihydrochloridumC20H24N2O2.2HClP.t.l: 397,3Quinin dihydroclorid l (8S,9R)-6-methoxycinchonan-9-ol dihydroclorid, phi cha t 99,0 n 101,0%C20H24N2O2.2HCl, tnh theo ch phm sy kh.Tnh chtBt trng hay gn nh trng. Rt tan trong n
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
DEXAMETHASON NATRI PHOSPHATDexamethasoni natrii phosphasC22H28FNa2O8PP.t.l: 516,4Dexamethason natri phosphat l 9-fluoro-11,17-dihydroxy-16-methyl-3, 20-dioxopregna-1,4-dien21-yl natri phosphat, phi cha t 97,0 n 103,0% C22H28FNa2O8P, tnh theo ch phm kh
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
BetamethasoNBetamethsoniumC22H29FO5P.t.l: 392.5Betamethason l 9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-dien-3,20-dion, phi cha t 97,0n 103,0% C22H29FO5, tnh theo ch phm khan.Tnh chtBt kt tinh trng hay gn nh trng.Thc t khng tan trong nc, t
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
METHYLPREDNISOLON ACETATMethylprednisoloni acetasC24H32O6P.t.l: 416,5Methylprednisolon acetat l 11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl acetat, ph i ch a t 97,0 n 103,0% C24H32O6, tnh theo ch phm lm kh.Tnh chtBt kt tinh mu trng hay
Albany College of Pharmacy and Health Sciences - PHARMACEUT - 101
ASTEMIZOLAstemizoliumC28H31FN4OP.t.l.: 458.6Astemizol l 1-(4-fluorobenzyl)-N-[1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl]-1H- benzimidazol2-amin, n phi cha t 99,0% n 101,0% C28H31FN4O, tnh theo ch phm khan.Tnh cht:Bt trng hoc gn nh trng, thc t khng